Anifrolumab versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2193; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Cardiovascular • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|